RT @NatRevClinOncol: Interesting new article by ESMO outlines a framework to rank genomic alterations as targets for cancer precision medic…
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @NatRevClinOncol: Interesting new article by ESMO outlines a framework to rank genomic alterations as targets for cancer precision medic…
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @NatRevClinOncol: Interesting new article by ESMO outlines a framework to rank genomic alterations as targets for cancer precision medic…
RT @NatRevClinOncol: Interesting new article by ESMO outlines a framework to rank genomic alterations as targets for cancer precision medic…
RT GustaveRoussy "RT FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decrease the misinterpretation of genomic reports together with overtreatment. Now we need to work on… http
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @NatRevClinOncol: Interesting new article by ESMO outlines a framework to rank genomic alterations as targets for cancer precision medic…
Interesting new article by ESMO outlines a framework to rank genomic alterations as targets for cancer precision medicine: the 'ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)': https://t.co/lnvXnYZBJE
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @GarbineLizeaga: "A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionab…
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)" https://t.co/iQBXmY3mPt
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
RT @FAndreMD: ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decreas…
ESMO released a scale to interpret genomic alterations found by NGS in daily practice or access programs. this should decrease the misinterpretation of genomic reports together with overtreatment. Now we need to work on implementation. tks to all authors !